My INR was 2.8 last week and I was instructed to resume my usual warfarin (Coumadin) dose of 6 mg daily; today my INR is 3.3 after eating a lot of coleslaw. Should I resume the 6 mg daily warfarin dose?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 11, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Management of INR 3.3 After Coleslaw Consumption

Hold tonight's dose of warfarin and resume at a reduced dose of 5 mg daily (down from 6 mg), then recheck INR in 3-5 days. The coleslaw consumption (high vitamin K) paradoxically suggests the INR rise is despite dietary antagonism, indicating your warfarin sensitivity has increased or another factor is at play.

Rationale for Dose Adjustment

Your INR of 3.3 falls into a critical management zone. According to American College of Chest Physicians guidelines, when the INR is above the therapeutic range but ≤5 in patients without bleeding or need for urgent procedures, the warfarin dose should be reduced or the next dose omitted and resumed at a lower dose when the INR approaches the desired range 1.

Why Not Just Continue at 6 mg?

While some research suggests stable patients with minimal INR deviations (up to 3.3) can continue unchanged dosing 2, 3, your situation has a key difference: the coleslaw consumption should have lowered your INR, not allowed it to rise. Coleslaw (cabbage) is rich in vitamin K, which antagonizes warfarin 4. The fact that your INR increased from 2.8 to 3.3 while consuming large amounts of vitamin K suggests:

  • Your actual warfarin sensitivity is higher than your current dose reflects
  • Once you return to normal dietary habits (less vitamin K), your INR will likely rise further
  • The 6 mg dose is now excessive for your current metabolic state

Specific Management Algorithm

Immediate actions:

  • Skip tonight's dose (one dose omission)
  • Resume tomorrow at 5 mg daily (approximately 15% dose reduction from 42 mg/week to 35 mg/week)
  • Recheck INR in 3-5 days 1
  • Return to consistent, moderate vitamin K intake - avoid both large amounts and complete avoidance 4

You do NOT need vitamin K supplementation because:

  • Your INR is <5 1
  • You have no bleeding symptoms
  • Vitamin K would cause excessive INR drop and potential warfarin resistance 1

Bleeding Risk Assessment

Your bleeding risk remains low at INR 3.3, but increases sharply above 5 1. The guidelines emphasize that even with excessively prolonged INR, the absolute daily risk of bleeding is low unless you have intrinsic bleeding risk factors 1.

Monitor for bleeding signs 4:

  • Unusual bruising
  • Nosebleeds or bleeding gums
  • Blood in urine (pink/brown) or stool (red/black)
  • Prolonged bleeding from cuts
  • Headaches, dizziness, weakness

The Coleslaw Factor: Critical Pitfall

Common misconception: "I ate vitamin K-rich foods, so my INR went up because warfarin and vitamin K interact."

Reality: Vitamin K opposes warfarin's effect. Your INR should have decreased or stayed stable with coleslaw consumption. The rise to 3.3 indicates the 6 mg dose is now too high for your current state.

Going forward: Maintain consistent vitamin K intake (don't avoid it completely, but don't binge on leafy greens) 4. The FDA label specifically warns against "drastic changes in dietary habits, such as eating large amounts of leafy, green vegetables" - the key word is changes, not avoidance.

Follow-up Strategy

At your 3-5 day recheck:

  • If INR 2.0-3.0: Continue 5 mg daily, recheck in 1 week, then extend to 2-4 weeks if stable
  • If INR <2.0: Increase to 5.5 mg daily, recheck in 3-5 days
  • If INR 3.1-4.0: Continue 5 mg daily, recheck in 3-5 days
  • If INR >4.0: Hold one additional dose, consider low-dose oral vitamin K (1-2.5 mg) if >5.0 1

The goal is achieving stable therapeutic anticoagulation (typically INR 2.0-3.0) while minimizing both thrombotic and bleeding risks 1.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.